Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:ONC)

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

PR Newswire 13 days ago

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

PR Newswire November 11, 2024

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

PR Newswire October 4, 2024

Oncolytics Biotech reports positive results from breast cancer study

Jocelyn Aspa September 19, 2024

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

PR Newswire September 19, 2024

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

PR Newswire September 6, 2024

Sernova Corp. Announces Appointment of New Chief Executive Officer

GlobeNewswire August 12, 2024

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

PR Newswire August 2, 2024

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights

PR Newswire August 1, 2024
View More News ››

Opinion & Analysis (TSX:ONC)

Buzz on the Bullboards: New Year, New Attractive Stocks

Omri Wallach January 9, 2020

Target Price Raised Ninefold on Biotech After Share Consolidation

Streetwise Reports June 6, 2018

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014
View More Opinion ››

Bullboard Posts (TSX:ONC)

RE:RE:RE:Pancreatic surgeon Dr. Marty Makary appointed head of FDA

... neither Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CBER), nor [ Jefferies] analysts...
Noteable - 2 hours ago

OT: Asthma drug "Singular" linked to mental health problems

Launched in 1998, the risk of “serious neuropsychiatric events” including agitation, hostility, depression, anxiousness, insomnia and...
Noteable - 2 hours ago

RE:What YouTube CEO shared before she died of lung cancer

In the message, Susan Wojcicki said that she and her husband, Dennis Troper, had actively supported cancer research before her diagnosis....
Noteable - 5 hours ago

What YouTube CEO shared before she died of lung cancer

“At the end of 2022, I was diagnosed with lung cancer,” Wojcicki’s message began. “I had almost no symptoms and was running a few miles a...
Noteable - 5 hours ago

RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"

November 25, 2024 - Pfizer’s sales surge in Q3. In the third quarter, part of Pfizer’s revenue increase (PDF) from $13.2...
Noteable - 6 hours ago

RE:RE:RE:RE:RE:RE:How does Accelerated Approval work

With Replimmune leading the way on Accelerated Approval (AA) and the FDA granting Replimmune's intratumorally (IT) delivered OV...
Noteable - 6 hours ago
View more Bullboard ››

Good Natured Products Inc

Good Natured Products Inc

good natured Products Inc. offers an assortment of plant-based products made all, or in part, from the maximum possible ...
View More »